Melissa Wellons is an Endocrinology/Metabolic physician affiliated with Vanderbilt University Medical Center. OpenAlex indexes 120 publications with 4,140 citations (h-index 37).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3601 The Vanderbilt Clinic
Nashville, TN 372320475
Telephone
615-936-2000Provider last certified this registry record 15 Mar 2022.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
66.9%Statin25.5%Atorvastatin Calcium47%Rosuvastatin Calcium37%Pravastatin Sodium16%Part D<11 patientsPCSK9 Inhibitor25%Repatha Sureclick84%Praluent Pen16%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
29%GLP-1 receptor agonist19.4%Ozempic49%Mounjaro35%Trulicity17%Part D<11 patientsBiguanide (metformin)9.7%Metformin Hcl Er100%Part D≥11 patientsHormonal (systemic)
4%l-Thyroxine4%Levothyroxine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2012–2017 per NIH RePORTER. The latest:
- Trajectory of Anti-Mullerian Hormone Decline and CVD Risk in CARDIA Women
Vanderbilt University Medical Center
FY2017$83,528R03HL135453 - Trajectory of Anti-Mullerian Hormone Decline and CVD Risk in CARDIA Women
Vanderbilt University Medical Center
FY2016$83,399R03HL135453 - Increased Cardiovacular Risk and Early Natural Menopause in a Biracial Cohort
Vanderbilt University
FY2012$133,192K23HL087114
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Women's Reproductive Milestones and Cardiovascular Disease Risk: A Review of Reports and Opportunities From the CARDIA Study
Journal of the American Heart Association
2023 - Relationship Between Age at Menopause, Obesity, and Incident Heart Failure: The Atherosclerosis Risk in Communities Study
Journal of the American Heart Association
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Wei Zheng, MD, PhD, MPH
Vanderbilt University Medical Center
Brian Rini, MD
Vanderbilt University Medical Center
William Schaffner, MD
Vanderbilt University Medical Center
Jordan Berlin, MD
Vanderbilt University Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”